NEUROTYPE INC.
Medtech · Private
NeuromarkR™ software that interfaces with EEG systems to quantify cue-induced craving in opioid use disorder patients via Event-Related Potential biomarkers
- Grants
- $1.9M
- 6 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 4
- 1 granted · 3 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2020202120222023202420252026
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Mobile brain sensing platform for detection of opioid craving and treatment response | $235,084 | |
| Federal grant | Department of Health and Human Services · Phase I · Mobile brain sensing platform for detection of opioid craving and treatment response | $54,911 | |
| Federal grant | Department of Health and Human Services · Phase I · Mobile brain sensing platform for detection of opioid craving and treatment response | $114,916 | |
| Federal grant | Department of Health and Human Services · Phase I · Closed-loop attention bias modification brain training for opioid use disorder | $326,672 | |
| Federal grant | Department of Health and Human Services · Phase II · Cue-induced drug craving monitoring for opioid use disorder with visual evoked potentials | $328,963 | |
| Federal grant | Department of Health and Human Services · Phase II · Cue-induced drug craving monitoring for opioid use disorder with visual evoked potentials | $870,345 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2250 | AMEBAGONE INC | — | — |
| 2251 | COLORADO PHOTOPOLYMER SOLUTIONS, LLC | — | — |
| 2252 | ZINN LABS, INC. | — | — |
| 2253 | NEUROTYPE INC. | — | — |
| 2254 | ENGINEERING RESOURCES GROUP INC | — | — |
| 2255 | GLYCIOME, LLC | — | — |
| 2256 | SUPERFLUID DX, INC. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Assessing Motivated Attention With Cue Reactivityapplication
- Assessing Motivated Attention with Cue Reactivitygranted
- Assessing Cue Reactivityapplication
- Mobile Brain Sensing Platform For Detection Of Opioid Craving And Treatment Responseapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.